Summary
Limb development constitutes a central model for the study of tissue and organ patterning; yet, the mechanisms that regulate the patterning of limb vasculature have been left understudied. Vascular patterning in the forming limb is tightly regulated in order to ensure sufficient gas exchange and nutrient supply to the developing organ. Once skeletogenesis is initiated, limb vasculature undergoes two seemingly opposing processes: vessel regression from regions that undergo mesenchymal condensation; and vessel morphogenesis. During the latter, vessels that surround the condensations undergo an extensive rearrangement, forming a stereotypical enriched network that is segregated from the skeleton. In this study, we provide evidence for the centrality of the condensing mesenchyme of the forming skeleton in regulating limb vascular patterning. Both Vegf loss- and gain-of-function experiments in limb bud mesenchyme firmly established VEGF as the signal by which the condensing mesenchyme regulates the vasculature. Normal vasculature observed in limbs where VEGF receptors Flt1, Flk1, Nrp1 and Nrp2 were blocked in limb bud mesenchyme suggested that VEGF, which is secreted by the condensing mesenchyme, regulates limb vasculature via a direct long-range mechanism. Finally, we provide evidence for the involvement of SOX9 in the regulation of Vegf expression in the condensing mesenchyme. This study establishes Vegf expression in the condensing mesenchyme as the mechanism by which the skeleton patterns limb vasculature.
- Skeleton
- Skeletogenesis
- Anti-angiogenic
- Vascular patterning
- Limb development
- SOX9
- VEGF
- PRX1-Cre
- SOX9-Cre
- Mouse
Footnotes
-
We are grateful to Dr C. Tabin for the Prx1-Cre mice, to Dr A. Nagy for the rtTA and Vegf-IRES-LacZ mice, to Dr E. Keshet for the tetO-Vegf mice, to Dr L. Kolodkin for the floxed-Nrp1 and Nrp2 mice, to Dr M. Tessier-Lavigne for Nrp2-LacZ mice, and to Dr P. Thorpe for the Rafl-1 antibody. We thank Ms S. Kerief for expert technical support, Mr N. Konstantin for expert editorial assistance, and members of the Zelzer laboratory for advice and suggestions. This work was supported by grants from Israel Science Foundation grant 499/05, Minerva grant M941, The Leo and Julia Forchheimer Center for Molecular Genetics, The Stanley Chais New Scientist Fund, The Kirk Center for Childhood Cancer and Immunological Disorders, The David and Fela Shapell Family Center for Genetic Disorders Research and The Clore Center for Biological Physics. E.Z. is the incumbent of the Martha S. Sagon Career Development Chair.
- Accepted February 16, 2009.